https://www.ophthalmologytimes.com/view/vivavision-everads-collaborate-to-develop-therapies-for-retinal-diseases
The delivery of VivaVision's molecules via the suprachoroidal space using Everads' technology is expected to lead to novel treatments for retinal diseases.
Create an account or login to join the discussion